Daniel Peckham

Active research focusing on various aspects of CF, bronchiectasis, and Primary Ciliary Dyskinesia. Work focusing on mechanisms of lung and systemic inflammation and drug modulation, NLRP3, Gut microbiome and the gut lung axis, airborne transmission, drug allergy, CF liver disease, cancer and CFTR dysfunction, adherence, disease patterns, electronic patient records and clinical trials.